Study on biopharmaceutics classification system of Chinese materia medica for Gegen Qinlians Tablets based on anti-inflammatory activity.
10.19540/j.cnki.cjcmm.20190513.301
- Author:
Zi-Yu WANG
1
;
Yang LIU
1
;
Xin ZHANG
1
;
Yan-Ping LI
1
;
Ya-Ru CHENG
1
;
Ling DONG
1
Author Information
1. Beijing University of Chinese Medicine Beijing 102488,China.
- Publication Type:Journal Article
- Keywords:
Gegen Qinlian Tablets;
biopharmaceutics classification system of Chinese materia medica;
intestinal permeability;
solubility
- MeSH:
Anti-Inflammatory Agents;
pharmacology;
Biopharmaceutics;
classification;
Drugs, Chinese Herbal;
classification;
pharmacology;
Materia Medica;
classification;
Tablets
- From:
China Journal of Chinese Materia Medica
2019;44(17):3662-3671
- CountryChina
- Language:Chinese
-
Abstract:
The research on biopharmaceutics classification system of Chinese materia medica( CMMBCS) should be finally implemented to the holistic research level of traditional Chinese medicine compounds,while the overall biopharmaceutical properties of traditional Chinese medicine compounds are not only the sum of solubility and permeability of each component. In this study,Gegen Qinlian Tablets was used as the research object,and the contents of 12 representative components,i.e. puerarin,daidzin,baicalin,daidzein,wogonoside,baicalein,wogonin,glycyrrhizic acid,coptisine hydrochloride,epiberberine,berberine hydrochloride and palmatine hydrochloride,were simultaneously determined by HPLC to obtain the mass weight of each component. The in vitro lipopolysaccharide( LPS)-induced RAW264. 7 cells inflammation model was established to investigate the anti-inflammatory effects of 12 representative components and obtain the efficacy weight of each component. In order to obtain the number of doses and effective permeability coefficient which can represent the overall biopharmaceutical properties of Gegen Qinlian Tablets,mass weight was combined with efficacy weight to integrate the solubility and permeability data of each component determined by typical shake flask method and in situ single pass intestinal perfusion model respectively. The results indicated that Gegen Qinlian Tablets should be categorized Ⅳ drug of the CMMBCS with low solubility and low permeability.
